CBI vs CBI: CVC files preliminary probe report in sealed cover in SC

Agencies
November 12, 2018

New Delhi, Nov 12: The Central Vigilance Commission (CVC) Monday filed its preliminary probe report relating to CBI Director Alok Kumar Verma in a sealed cover in the Supreme Court.

A bench comprising Chief Justice Ranjan Gogoi and Justice S K Kaul took the report on record and fixed the matter for next hearing on November 16. 

During the hearing, interim CBI Director M Nageswar Rao also filed report on decisions taken by him since October 23 to 26, when the apex court had ordered for the probe. 

Solicitor General (SG) Tushar Mehta, appearing for the CVC, told the court that former apex court judge A K Patnaik supervised the CVC inquiry which was completed on November 10.

The CJI observed that the Registry was open on Sunday also but no intimation was given to the Registrar regarding filing of the report. 

Later the SG tendered an apology and said though he was not explaining the circumstances there was delay on their part in submitting the report. 

On October 26, the top court had appointed Justice Patnaik to supervise the ongoing inquiry of CVC against Verma.

The apex court had also issued notices to the Centre and the CVC seeking their replies on Verma's petition challenging the government's decision to divest him of his powers as CBI chief and sending him on leave.

Verma's deputy Rakesh Asthana, Special Director CBI, was also sent on leave by the Centre.

The court on October 26 had also set a deadline of two weeks for the CVC to complete the preliminary inquiry against the CBI director.

It had also barred Rao, who has been given interim charge of the CBI, from taking any major decision.

It had said that a list of all the decisions taken by Rao since October 23 including decisions with regard to transfer of investigations, change of investigating officer(s) etc will be furnished to the court in a sealed cover on or before November 12, 2018 whereafter orders as would be appropriate will be passed by the court." 

Mehta had said that the CVC has been conducting an inquiry into the allegations made in the August 24 note/letter of the Cabinet Secretary with regard to Verma.

Besides the plea filed by Verma, the court is also seized of the PIL filed by NGO Common Cause, which has sought a probe by special investigation team against CBI officers including Asthana, and had issued notices to the Centre, CBI, CVC, Asthana, Verma and Rao asking them to respond to it by November 12.

Asthana has also moved the Supreme Court with a separate petition in the matter and has sought removal of Verma from the post of CBI Director. 

Later, on November 4, Congress leader Mallikarjun Kharge had moved the top court contending that divesting Verma of his statutory powers and functions is "completely illegal and arbitrary".

In an interlocutory application filed in the pending petition, Kharge, who is also a member of the three-member selection committee which appoints the CBI director, said, "As a concerned stakeholder he brings to the attention of the court the brazen and illegal actions" of the political executive in interfering with the independent functioning of the CBI director.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 16,2020

Thiruvananthapuram, Apr 16: Seven fresh cases of COVID-19 were reported from Kerala on Thursday, taking the total number of active cases to 147 in the state,even as over 88,000 people are under observation.

On Wednesday, only one positive case had been reported, thelowest in weeks.

While Kannur reported four cases, two were from Kozhikode and one from Kasaragod, Chief Minister Pinarayi Vijayan told reportershere.

Five of those affected had come from abroad, while two have got it through contact with infected people.

Samples of 27 people, including 24 from the worst affected Kasaragod, have turned negative on Thursday.

He said 394 coronavirus cases have so farbeen detected from the state.

Over 80,000 people are under observation, including 532 in various hospitals.

Vijayan said 17,400 samples have been sent for testing of which 16,459 have returned negative.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 29,2020
Agra, Mar 29: A 39-year-old man, who had walked almost 200 kilometers from Delhi to reach his home in Morena in Madhya Pradesh, collapsed and died in Agra on Saturday. 
 
The man, identified as Ranveer Singh, worked as home delivery boy for a private restaurant in the national capital.
 
According to police, the victim collapsed near Kailash turning of the national highway-2, after which a local hardware store owner Sanjay Gupta rushed to the victim. 
 
Sikandra station house officer (SHO) Arvind Kumar, said, 'Gupta made the victim lie on a carpet and offered tea and biscuit. The victim complained about chest pain and also called his brother-in-law Arvind Singh over phone to share his health condition. At around 6.30 P.m, the victim passed away and local police was informed. "
 
Ranveer had left for his native village on Friday morning on foot. It is likely that exhaustion of 200-km walk might have caused chest pain. 
 
The SHO said,"On the entire NH-2 stretch, UP policemen are present with food packets and water for such persons but Ranveer's death is unfortunate. "
 
After the death, policemen took the victim's body for post-mortem. The autopsy report is yet to be re eased. 
 
According to information available, Ranveer was working in Delhi's Tughlakabad for the past three- years. He is survived by three children including two daughters. He belongs to a family of farmers and was the main bread winner for his family.
 
His family has been brought to Agra to take the body back to their village for the last rites.

Comments

Angry Indian
 - 
Monday, 30 Mar 2020

very sad news....this is the condition of hindu people after they adopt hindutva idology.

 

Politician enjoying playing ludo and watching ramayan, after complete lockdown, not even bothered by government about their transport,

 

modi spend crore on statue, but no hospital

 

this is the hindu rastra you want right...enjoy marons

 

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.